Stock Analysis

New Horizon Health Full Year 2022 Earnings: Revenues Beat Expectations

Source: Shutterstock

New Horizon Health (HKG:6606) Full Year 2022 Results

Key Financial Results

  • Revenue: CN¥765.0m (up 260% from FY 2021).
  • Net loss: CN¥79.2m (loss narrowed by 97% from FY 2021).
SEHK:6606 Earnings and Revenue Growth March 14th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

New Horizon Health Revenues Beat Expectations

Revenue exceeded analyst estimates by 14%.

Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Healthcare industry in Hong Kong.

Performance of the Hong Kong Healthcare industry.

The company's shares are down 12% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 3 warning signs for New Horizon Health that you should be aware of.

Valuation is complex, but we're helping make it simple.

Find out whether New Horizon Health is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis